SNSW(SH:688117) Xin Lang Cai Jing·2025-08-15 01:08Core Viewpoint - Saintno Bio (688117.SH) reported its mid-year results for 2025, showing a total revenue of 338 million yuan and a net profit attributable to shareholders of 88.96 million yuan, indicating a stable financial performance in the first half of the year [1]. Financial Performance - The company's total revenue for the first half of 2025 was 338 million yuan [1]. - The net profit attributable to shareholders was 88.96 million yuan [1]. - The net cash inflow from operating activities was 81.66 million yuan [1]. Financial Ratios - The latest debt-to-asset ratio is 43.45%, which is an increase of 1.48 percentage points from the previous quarter and an increase of 3.80 percentage points from the same period last year [3]. - The latest gross profit margin is 56.89%, reflecting a decrease of 2.70 percentage points compared to the same period last year [3]. - The latest return on equity (ROE) is 8.96% [3]. Earnings Per Share - The diluted earnings per share (EPS) is 0.57 yuan [4]. Asset Management - The latest total asset turnover ratio is 0.20 times [5]. - The latest inventory turnover ratio is 0.47 times [5]. Shareholder Structure - The number of shareholders is 11,100, with the top ten shareholders holding a total of 79.91 million shares, accounting for 50.77% of the total share capital [5]. - The largest shareholder is Sichuan Saino Investment Co., Ltd., holding 30.39% of the shares [5].